Year |
Citation |
Score |
2023 |
Callegari K, Dash S, Uchida H, Shingai Y, Liu C, Khodarkovskaya A, Lee Y, Ito A, Lopez A, Zhang T, Xiang J, Kluk MJ, Sanchez T. Molecular profiling of the stroke-induced alterations in the cerebral microvasculature reveals promising therapeutic candidates. Proceedings of the National Academy of Sciences of the United States of America. 120: e2205786120. PMID 37058487 DOI: 10.1073/pnas.2205786120 |
0.502 |
|
2019 |
Al-Kawaaz M, Sanchez T, Kluk MJ. Evaluation of S1PR1, pSTAT3, S1PR2, FOXP1 Expression in Aggressive, Mature B Cell Lymphomas. Journal of Hematopathology. 12: 57-65. PMID 31404445 DOI: 10.1007/S12308-019-00354-Y |
0.587 |
|
2017 |
Ryan RJH, Petrovic J, Rausch DM, Zhou Y, Lareau CA, Kluk MJ, Christie AL, Lee WY, Tarjan DR, Guo B, Donohue LKH, Gillespie SM, Nardi V, Hochberg EP, Blacklow SC, et al. A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas. Cell Reports. 21: 784-797. PMID 29045844 DOI: 10.1016/J.Celrep.2017.09.066 |
0.368 |
|
2016 |
Bernasconi-Elias P, Hu T, Jenkins D, Firestone B, Gans S, Kurth E, Capodieci P, Deplazes-Lauber J, Petropoulos K, Thiel P, Ponsel D, Hee Choi S, LeMotte P, London A, Goetcshkes M, ... ... Kluk MJ, et al. Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies. Oncogene. PMID 27157619 DOI: 10.1038/Onc.2016.133 |
0.331 |
|
2016 |
Drier Y, Cotton MJ, Williamson KE, Gillespie SM, Ryan RJ, Kluk MJ, Carey CD, Rodig SJ, Sholl LM, Afrogheh AH, Faquin WC, Queimado L, Qi J, Wick MJ, El-Naggar AK, et al. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nature Genetics. PMID 26829750 DOI: 10.1038/Ng.3502 |
0.315 |
|
2016 |
Ryan RJ, Petrovic J, Rausch D, Lareau C, Lee W, Donohue L, Christie AL, Gillespie S, Kluk MJ, Nardi V, Faryabi RB, Hochberg EP, Weinstock DM, Bernstein BE, Aster JC, et al. Notch-Regulated Enhancers in B-Cell Lymphoma Activate MYC and Potentiate B-Cell Receptor Signaling Blood. 128: 457-457. DOI: 10.1182/Blood.V128.22.457.457 |
0.399 |
|
2016 |
Ryan RJ, Petrovic J, Rausch DM, Lee W, Kluk M, Donohue L, Gillespie S, Aster JC, Pear WS, Bernstein BE. Abstract 886: Notch signaling activates B-cell specific enhancers to drive oncogene targets in B-cell lymphoma Cancer Research. 76: 886-886. DOI: 10.1158/1538-7445.Am2016-886 |
0.404 |
|
2016 |
Stiles BM, Nasar A, Hussein MK, Ghaly GR, Ahmed MR, Port JL, Lee PC, Nguyen AB, Shostak E, Borczuk AC, Kluk MJ, Altorki NK. Routine molecular testing of resected early-stage lung adenocarcinoma with targeted next-generation sequencing demonstrates a high rate of actionable mutations Journal of Thoracic Oncology. 11: S44-S45. DOI: 10.1016/J.Jtho.2015.12.075 |
0.329 |
|
2015 |
Kim GS, Yang L, Zhang G, Zhao H, Selim M, McCullough LD, Kluk MJ, Sanchez T. Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke. Nature Communications. 6: 7893. PMID 26243335 DOI: 10.1038/Ncomms8893 |
0.559 |
|
2015 |
Carey CD, Gusenleitner D, Chapuy B, Kovach AE, Kluk MJ, Sun HH, Crossland RE, Bacon CM, Rand V, Dal Cin P, Le LP, Neuberg D, Sohani AR, Shipp MA, Monti S, et al. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens. The Journal of Molecular Diagnostics : Jmd. 17: 19-30. PMID 25468432 DOI: 10.1016/J.Jmoldx.2014.08.006 |
0.301 |
|
2014 |
Gerhardt DM, Pajcini KV, D'altri T, Tu L, Jain R, Xu L, Chen MJ, Rentschler S, Shestova O, Wertheim GB, Tobias JW, Kluk M, Wood AW, Aster JC, Gimotty PA, et al. The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells. Genes & Development. 28: 576-93. PMID 24637115 DOI: 10.1101/Gad.227496.113 |
0.321 |
|
2014 |
Knoechel B, Roderick JE, Williamson KE, Zhu J, Lohr JG, Cotton MJ, Gillespie SM, Fernandez D, Ku M, Wang H, Piccioni F, Silver SJ, Jain M, Pearson D, Kluk MJ, et al. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nature Genetics. 46: 364-70. PMID 24584072 DOI: 10.1038/Ng.2913 |
0.328 |
|
2014 |
Grayson AR, Walsh EM, Cameron MJ, Godec J, Ashworth T, Ambrose JM, Aserlind AB, Wang H, Evan GI, Kluk MJ, Bradner JE, Aster JC, French CA. MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma Oncogene. 33: 1736-1742. PMID 23604113 DOI: 10.1038/Onc.2013.126 |
0.324 |
|
2014 |
Knoechel B, Roderick J, Williamson K, Zhu J, Lohr J, Cotton M, Gillespie S, Fernandez D, Ku M, Wang H, Piccioni F, Silver S, Jain M, Pearson D, Kluk M, et al. Abstract 4782: Epigenetic resistance to Notch inhibition in T cell acute lymphoblastic leukemia Cancer Research. 74: 4782-4782. DOI: 10.1158/1538-7445.Am2014-4782 |
0.328 |
|
2013 |
Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA, Dorfman D, Pinkus G, Weigert O, Hornick JL, Chirieac LR, Hirsch M, Oh DJ, South AP, Leigh IM, et al. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. Plos One. 8: e67306. PMID 23825651 DOI: 10.1371/Journal.Pone.0067306 |
0.324 |
|
2013 |
Zhang G, Yang L, Kim GS, Ryan K, Lu S, O'Donnell RK, Spokes K, Shapiro N, Aird WC, Kluk MJ, Yano K, Sanchez T. Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. Blood. 122: 443-55. PMID 23723450 DOI: 10.1182/Blood-2012-11-467191 |
0.638 |
|
2013 |
Kluk MJ, Ryan KP, Wang B, Zhang G, Rodig SJ, Sanchez T. Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration. Laboratory Investigation; a Journal of Technical Methods and Pathology. 93: 462-71. PMID 23419711 DOI: 10.1038/Labinvest.2013.7 |
0.634 |
|
2013 |
Walsh EM, Grayson AR, Cameron MJ, Godec J, Ashworth T, Aserlind AB, Wang H, Evan G, Kluk MJ, Bradner JE, Aster JC, French CA. Abstract B39: MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Pms-B39 |
0.32 |
|
2012 |
Kluk MJ, Chapuy B, Sinha P, Roy A, Dal Cin P, Neuberg DS, Monti S, Pinkus GS, Shipp MA, Rodig SJ. Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas. Plos One. 7: e33813. PMID 22511926 DOI: 10.1371/Journal.Pone.0033813 |
0.313 |
|
2012 |
Neff T, Sinha AU, Kluk MJ, Zhu N, Khattab MH, Stein L, Xie H, Orkin SH, Armstrong SA. Polycomb repressive complex 2 is required for MLL-AF9 leukemia. Proceedings of the National Academy of Sciences of the United States of America. 109: 5028-33. PMID 22396593 DOI: 10.1073/Pnas.1202258109 |
0.302 |
|
2011 |
Wang X, Werneck MB, Wilson BG, Kim HJ, Kluk MJ, Thom CS, Wischhusen JW, Evans JA, Jesneck JL, Nguyen P, Sansam CG, Cantor H, Roberts CW. TCR-dependent transformation of mature memory phenotype T cells in mice. The Journal of Clinical Investigation. 121: 3834-45. PMID 21926465 DOI: 10.1172/Jci37210 |
0.336 |
|
2003 |
Kluk MJ, Colmont C, Wu MT, Hla T. Platelet-derived growth factor (PDGF)-induced chemotaxis does not require the G protein-coupled receptor S1P1 in murine embryonic fibroblasts and vascular smooth muscle cells. Febs Letters. 533: 25-8. PMID 12505153 DOI: 10.1016/S0014-5793(02)03742-0 |
0.636 |
|
2002 |
Kluk MJ, Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochimica Et Biophysica Acta. 1582: 72-80. PMID 12069812 DOI: 10.1016/S1388-1981(02)00139-7 |
0.655 |
|
2001 |
Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ. Lysophospholipids--receptor revelations. Science (New York, N.Y.). 294: 1875-8. PMID 11729304 DOI: 10.1126/Science.1065323 |
0.749 |
|
2001 |
Kluk MJ, Hla T. Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circulation Research. 89: 496-502. PMID 11557736 DOI: 10.1161/Hh1801.096338 |
0.608 |
|
2000 |
Hla T, Lee MJ, Ancellin N, Thangada S, Liu CH, Kluk M, Chae SS, Wu MT. Sphingosine-1-phosphate signaling via the EDG-1 family of G-protein-coupled receptors. Annals of the New York Academy of Sciences. 905: 16-24. PMID 10818438 DOI: 10.1111/J.1749-6632.2000.Tb06534.X |
0.716 |
|
1999 |
Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'afi RI, Hla T. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell. 99: 301-12. PMID 10555146 DOI: 10.1016/S0092-8674(00)81661-X |
0.729 |
|
1999 |
Hla T, Lee MJ, Ancellin N, Liu CH, Thangada S, Thompson BD, Kluk M. Sphingosine-1-phosphate: extracellular mediator or intracellular second messenger? Biochemical Pharmacology. 58: 201-7. PMID 10423159 DOI: 10.1016/S0006-2952(99)00086-6 |
0.729 |
|
1999 |
Hla T, Lee M, Anellin N, Liu CH, Thangada S, Kluk M. EDG-1 family of sphingosine-1-phosphate (SPP) receptors Prostaglandins & Other Lipid Mediators. 59: 93. DOI: 10.1016/S0090-6980(99)90328-3 |
0.748 |
|
Show low-probability matches. |